These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19999807)

  • 1. [Cyclooxygenase inhibitors in chemoprevention and treatment of esophageal squamous cell carcinoma].
    Szumiło J; Burdan F; Szumiło M; Lewkowicz D; Kedzierawska-Kurylcio A
    Pol Merkur Lekarski; 2009 Nov; 27(161):408-12. PubMed ID: 19999807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC; Kania J; Burnat G; Hahn EG
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin inhibits the proliferation of tobacco-related esophageal squamous carcinomas cell lines through cyclooxygenase 2 pathway.
    Zhou QZ; Liu HB; Ding XC; Li P; Zhang ST; Yu ZL
    Chin Med J (Engl); 2007 Dec; 120(23):2086-91. PubMed ID: 18167181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation.
    Yu L; Chen M; Li Z; Wen J; Fu J; Guo D; Jiang Y; Wu S; Cho CH; Liu S
    Mol Pharmacol; 2011 Mar; 79(3):608-17. PubMed ID: 21177414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
    J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of cyclooxygenase-2 in neoplasia.
    Fosslien E
    Ann Clin Lab Sci; 2000 Jan; 30(1):3-21. PubMed ID: 10678579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
    Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
    Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
    Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma.
    Pak KC; Lam KY; Law S; Tang JC
    Int J Mol Med; 2009 Jan; 23(1):121-9. PubMed ID: 19082515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.
    Carlton PS; Gopalakrishnan R; Gupta A; Liston BW; Habib S; Morse MA; Stoner GD
    Cancer Res; 2002 Aug; 62(15):4376-82. PubMed ID: 12154043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE; Jeon NK; Kim J; Lee EJ
    Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression in human esophageal carcinoma.
    Zimmermann KC; Sarbia M; Weber AA; Borchard F; Gabbert HE; Schrör K
    Cancer Res; 1999 Jan; 59(1):198-204. PubMed ID: 9892207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ; Halton DE; Hague A; Paraskeva C
    Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of COX-2 expression in human esophageal squamous cell carcinoma.
    Zhi H; Wang L; Zhang J; Zhou C; Ding F; Luo A; Wu M; Zhan Q; Liu Z
    Carcinogenesis; 2006 Jun; 27(6):1214-21. PubMed ID: 16352617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
    Stoner GD; Qin H; Chen T; Carlton PS; Rose ME; Aziz RM; Dixit R
    Carcinogenesis; 2005 Sep; 26(9):1590-5. PubMed ID: 15878914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C; Blumenthal RD; Li H; Stein R; Goldenberg DM; Burton J
    Cancer Res; 2002 Apr; 62(7):2029-33. PubMed ID: 11929821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
    Fong LY; Zhang L; Jiang Y; Farber JL
    J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.